The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017
Open Access
- 29 September 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 6 (10) , ofz419
Abstract
Central nervous system (CNS) infections remain a major public health problem in Sub-Saharan Africa, causing 15%–25% of AIDS-related deaths. With widespread availability of antiretroviral therapy (ART) and the introduction of improved diagnostics, the epidemiology of infectious meningitis is evolving. We prospectively enrolled adults presenting with HIV-associated meningitis in Kampala and Mbarara, Uganda, from March 2015 to September 2017. Participants had a structured, stepwise diagnostic algorithm performed of blood cryptococcal antigen (CrAg), CSF CrAg, Xpert MTB/RIF for tuberculous (TB) meningitis (TBM), Biofire multiplex polymerase chain reaction, and traditional microscopy and cultures. We screened 842 consecutive adults with HIV presenting with suspected meningitis: 57% men, median age 35 years, median CD4 26 cells/mcL, and 55% presented on ART. Overall, 60.5% (509/842) were diagnosed with first-episode cryptococcal meningitis and 7.4% (62/842) with second episode. Definite/probable TB meningitis was the primary diagnosis in 6.9% (58/842); 5.3% (n = 45) had microbiologically confirmed (definite) TB meningitis. An additional 7.8% (66/842) did not meet the diagnostic threshold for definite/probable TBM but received empiric TBM therapy. Bacterial and viral meningitis were diagnosed in 1.3% (11/842) and 0.7% (6/842), respectively. The adoption of a cost-effective stepwise diagnostic algorithm allowed 79% (661/842) to have a confirmed microbiological diagnosis at an average cost of $44 per person. Despite widespread ART availability, Cryptococcus remains the leading cause of HIV-associated meningitis. The second most common etiology was TB meningitis, treated in 14.7% overall. The increased proportion of microbiologically confirmed TBM cases reflects the impact of new improved molecular diagnostics.Keywords
Funding Information
- National Institute of Neurologic Diseases and Stroke (R01NS086312)
- Fogarty International Center (K01TW010268, R25TW009345)
- National Institute of Allergy and Infectious Diseases (T32AI055433)
- United Kingdom Medical Research Council/DfID/Wellcome Trust Global Clinical Trials (M007413)
- Wellcome Trust (210772/Z/18/Z)
This publication has 23 references indexed in Scilit:
- Improved diagnostic sensitivity for tuberculous meningitis with Xpert® MTB/RIF of centrifuged CSFThe International Journal of Tuberculosis and Lung Disease, 2015
- Evaluation of Fingerstick Cryptococcal Antigen Lateral Flow Assay in HIV-Infected Persons: A Diagnostic Accuracy Study: Figure 1.Clinical Infectious Diseases, 2015
- Epidemiology of Meningitis in an HIV-Infected Ugandan CohortThe American Journal of Tropical Medicine and Hygiene, 2015
- Bacterial Meningitis in Malawian Adults, Adolescents, and Children During the Era of Antiretroviral Scale-up and Haemophilus influenzae Type b Vaccination, 2000–2012Clinical Infectious Diseases, 2014
- Cost-Effective Diagnostic Checklists for Meningitis in Resource-Limited SettingsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
- Surveillance Programme of IN-patients and Epidemiology (SPINE): Implementation of an Electronic Data Collection Tool within a Large Hospital in MalawiPLOS Medicine, 2013
- Tuberculous meningitis: a uniform case definition for use in clinical researchThe Lancet Infectious Diseases, 2010
- Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitionsThe Lancet Infectious Diseases, 2010
- Diagnosis of cryptococcal and tuberculous meningitis in a resource-limited African settingTropical Medicine & International Health, 2010
- Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected casesBMC Infectious Diseases, 2010